Clancy 1985.
| Methods | Double‐blind, placebo‐controlled, prospective RCT over a 3‐month winter period in 1983 | |
| Participants | 50 patients from Royal Newcastle Hospital with COPD not taking corticosteroids or immunosuppressants Mean age of all participants: 65.5 |
|
| Interventions | NTHi vaccine and 2 placebo arms (enteric‐coated glucose tablets or 25 mg sodium tauroglycocholate). 3 courses of tablets were taken at 0, 28, 56 days. Each course was 2 tablets taken before breakfast on 3 consecutive days. | |
| Outcomes |
|
|
| Notes | Many participants were taking antibiotics and bronchodilator agents but were not taking steroids or immunosuppressants. Ciba‐Geigy (Australia) was cited for financial assistance in the Discussion. Trial was conducted at the Royal Newcastle Hospital. |
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | High risk | Randomisation was completed independently by a "Dr Smith" who kept the trial code allocations privately; how randomisation was performed was not disclosed. Whilst Dr Smith is not one of the trial authors, the exact nature of their relationship with the study is unknown. Randomisation in 1 arm had a very uneven male‐to‐female ratio |
| Allocation concealment (selection bias) | Unclear risk | No information provided |
| Blinding of participants and personnel (performance bias) All outcomes | Low risk | For each participant with an acute upper and lower respiratory infection, an infection questionnaire was completed by doctors who were not involved with the study and had no knowledge of the participant's test group |
| Blinding of outcome assessment (detection bias) All outcomes | Low risk |
|
| Incomplete outcome data (attrition bias) All outcomes | Low risk | All participants were accounted for. 2 participants out of the 50 originally enrolled died during the study |
| Selective reporting (reporting bias) | Low risk | Nil |
| Other bias | Low risk | Nil |